Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses
Antiviral Res
.
2020 Jun:178:104805.
doi: 10.1016/j.antiviral.2020.104805.
Epub 2020 Apr 21.
Authors
Mike Bray
,
Craig Rayner
,
François Noël
,
David Jans
,
Kylie Wagstaff
PMID:
32330482
PMCID:
PMC7172803
DOI:
10.1016/j.antiviral.2020.104805
No abstract available
Publication types
Editorial
Comment
MeSH terms
Antiviral Agents*
Betacoronavirus
COVID-19
Coronavirus Infections
Humans
Ivermectin
Pandemics
Pneumonia, Viral
SARS-CoV-2
Severe acute respiratory syndrome-related coronavirus*
Substances
Antiviral Agents
Ivermectin